Which stock gets a tree shake on good news, which sector is being investigated for price collusion, which acquisition is immediately accretive and who is a cruel mistress? Sarah looks at defenc...
After an oversubscribed £2.75 mln fundraise Thalia Therapeutics ( LON:THAT ) buys Sanmirna with its exclusive license in the U.S. for miRisten, a novel treatment for Acute Myeloid Leukemia. Chief...
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
(Alliance News) - The FTSE 100 was higher at midday on Wednesday, boosted by Segro after it rejected an "opportunistically timed" takeover proposal, and as the US and Iran reportedly prepare to restar...
Thalia Therapeutics PLC - biotechnology company developing innovative RNA therapeutics - Pretax loss is flat at GBP1.2 million in 2025 when compared to the year prior. Loss per share is 0.17 pence ver...